Regenerative Medicine Market By Therapy | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Regenerative Medicine Market
Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules Biologics); By Product (Autologous Cell-Based Products, Allogeneic Cell-Based Products, Acellular Products); By Application (Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, CNS, Others) & Geography - Forecast (2017-2022)
Report Code : HCR 0366
Published: 21 August, 2017   20% discount on this report
16

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Regenerative medicine is the new advancement in medical treatments. It is derived from the fields of tissue engineering, tissue science, biology, biochemistry, connected designing and other fields. It is meant to re-establish structure and function of damaged tissues and organs in the body. They are used to restore the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicinal solutions can be applied for a wide variety of disorders including neuro degenerative diseases like Parkinson’s and Alzheimer’s diseases and so on. The net market for regenerative medicine was estimated to be $XX billion in 2016 and is forecast to cross $XX billion mark by 2022 with a CAGR of XX % between 2017 and 2022.

Continuously growing demand for organs due to last stage organ failure is increasing the demand for regenerative medicine globally. Regenerative medicine market has been categorized based on therapy, product, application and geography. The market size for regenerative medicine in various regions for different applications such as orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, oncology, diabetes and others been covered in the report. Owing to the rising high medical reimbursement facilities and technological advancements, the regenerative medicine market is poised to exhibit a healthy growth in coming years. Rising awareness among government of various countries about the economic contribution of biotechnology is providing more opportunities for regenerative medicine market in recent times.

The market for regenerative medicine is segmented based on regions into North America, Europe, Asia-Pacific and Rest of the World. Competitive landscape for industry and market players are profiled with attributes of company overview, financial overview, business strategies and product portfolio. 

Sample Companies Profiled in this Report are:
  • Vertex Pharmaceuticals, Inc. (U.S.)
  • Medtronic, Inc. (U.S.)
  • Acelity L.P, Inc. (U.S.)
  • Smith & Nephew PLC (U.K.)
  • Nuvasive, Inc. (U.S.).
  • 10+
1.Regenerative Medicine Market Overview
2.Regenerative Medicine Market Executive Summary
3.Regenerative Medicine Market Landscape 
   3.1.Market Share Analysis
   3.2.Financial Analysis
   3.3.Patent Analysis
   3.4.Competitor Analysis
4.Regenerative Medicine Market Forces
   4.1.Market Drivers
      4.1.1. Rising Healthcare Expenditure and Aging Populations
      4.1.2. Rising Innovations in Biomaterials, Nanotechnology, Drug Delivery and Cell Therapies
   4.2.Market Constraints & Challenges
      4.2.1.Lower Awareness Levels in Emerging Economies
      4.2.2.High Treatment Costs and Research & Development Costs
   4.3.Attractiveness of Regenerative Medicine Market
      4.3.1.Power of Suppliers
      4.3.2.Power of Buyers
      4.3.3.Threat of Substitutes
      4.3.4.Threat of New entrants
      4.3.5.Degree of Competition
5.Regenerative Medicine Market – Strategic Analysis
   5.1.Value Chain Analysis
   5.2.Opportunities Analysis
      5.2.1.Growing Opportunities of Novel Stem Cell Technologies
      5.2.2.Increasing Economic Variance in Emerging Countries
      5.3.Market Life Cycle Analysis
6.Regenerative Medicine Market–  By  Therapy
   6.1.Introduction 
   6.2.Cell Therapy
   6.3.Gene Therapy
   6.4.Tissue Engineering
   6.5.Small Molecules, Biologics
7.Regenerative Medicine Market–  By Product
   7.1.Introduction
   7.2.Autologous Cell-Based Products
   7.3.Allogeneic Cell-Based Products
   7.4.Acellular Products
8.Regenerative Medicine Market– By  Application
   8.1.Introduction
   8.2.Orthopedic & Musculoskeletal Spine
   8.3.Dermatology
   8.4.Cardiovascular
   8.5.Central Nervous system
   8.6.Oncology
   8.7.Diabetes
   8.8.Others
9.Regenerative Medicine Market- By Geography
   9.1.Introduction
   9.2.North America
      9.2.1.U.S
      9.2.2.Canada 
      9.2.3.Mexico
   9.3.Europe
      9.3.1.U.K.
      9.3.2.Germany
      9.3.3.France
      9.3.4.Italy
      9.3.5.Spain
      9.3.6.Rest of Europe
   9.4.Asia-Pacific
      9.4.1.China
      9.4.2.Japan
      9.4.3.India
      9.4.4.South Korea
   9.5.RoW
      9.5.1.Africa
      9.5.2.South America 
      9.5.3.Middle-East        
10.Regenerative Medicine Market Entropy
11.Regenerative Medicine Market Company Profiles 
   11.1.Athersys, Inc. (U.S.)
   11.2.Exactech, Inc. (U.S.)
   11.3.Japan Tissue Engineering Co. Ltd (Japan)
   11.4.Medtronic (Ireland)
   11.5.Mesoblast, Inc. (U.S.)
   11.6.Vertex Pharmaceuticals, Inc. (U.S.)
   11.7.Organogenesis, Inc. (U.S.)
   11.8.Osiris Therapeutics, Inc. (U.S.)
   11.9.Smith & Nephew PLC (U.K.)
   11.10.Vericel Corporation (U.S.)
   11.11.Nuvasive, Inc. (U.S.)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
List of Tables:

Table 1: Regenerative Medicine Market Revenue, By Therapy, 2016-2022 ($Billion)
Table 2: Global Regenerative Medicine Market Revenue, By Application, 2016-2022 ($Billion)
Table 3: North America: Regenerative Medicine Market  Revenue, By Therapy, 2016-2022 ($Billion)
Table 4: North America: Regenerative Medicine Market Revenue, By Application, 2016-2022  ($Billion)
Table 5: Europe: Regenerative Medicine Market  Revenue, By Therapy, 2016-2022 ($Billion)
Table 6: Europe: Regenerative Medicine Market Revenue, By Application, 2016-2022 ($Billion)
Table 7: Asia Pacific: Regenerative Medicine Market  Revenue, By  Therapy, 2017-2022 ($Billion)
Table 8: Asia Pacific: Regenerative Medicine Market Revenue, By Application, 2017-2022 ($Billion)
Table 9: RoW: Regenerative Medicine Market  Revenue, By Therapy, 2016-2022 ($Billion)
Table 10: RoW: Regenerative Medicine Market Revenue, By Application, 2016-2022 ($Billion)


List of Figures:

Figure 1: Global Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 2: Global Regenerative Medicine Market Revenue, By Therapy, 2016, 2022 ($Billion)
Figure 3: Global Regenerative Medicine Market Revenue Share, By Application, 2016 (%)
Figure 4: Global Regenerative Medicine Market Revenue, By Geography, 2016, 2022 ($Billion)
Figure 5: Regenerative Medicine Market  Revenue Share, By Company, 2016 (%)
Figure 6: Nuvasive, Inc. 
Figure 7: Vertex Pharmaceuticals Incorporated
Figure 8: Medtronic Plc
Figure 9: Acelity L.P. Inc.
Figure 10: Smith & Nephew Plc
Figure 11: Earnings Per Share, By Company
Figure 12: Regenerative Medicines Patents, By Year, 2013- 2017
Figure 13: Regenerative Medicine Market: Value Chain Analysis
Figure 14: Cell Therapy: Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 15: Gene Therapy: Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 16: Tissue Engineering: Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 17: Small Molecules, Biologics : Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 18: Orthopedic & Musculoskeletal Spine: Global Regenerative Medicine Market Revenue, 2016-2022 ($Billion)
Figure 19: Dermatology: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 20: Cardiovascular: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 21: Central Nervous System: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 22: Oncology: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 23: Diabetes: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 24: Others: Global Regenerative Medicine Market Revenue, 2016-2022 ($Million)
Figure 25: Global Regenerative Medicine Market Revenue, By Geography, 2016,2022 ($Billion) 
Figure 26: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 27: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 28: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 29: U.S.: GDP – Composition of 2015, By End Use
Figure 30: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 31: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 32: Canada : Export and Import Value, 2012-2015 ($Billion)
Figure 33: Canada : GDP – Composition of 2015, By End Use
Figure 34: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 35: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 36: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 37: Mexico: GDP – Composition of 2015, By End Use
Figure 38: U.S.: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 39: Canada: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 40: Mexico: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 41: U.K.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 42: U.K.: GDP – Composition of 2015, By Sector of Origin
Figure 43: U.K.: Export and Import Value, 2012-2015 ($Billion)
Figure 44: U.K.: GDP – Composition of 2015, By End Use
Figure 45: Germany: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 46: Germany: GDP – Composition of 2015, By Sector of Origin
Figure 47: Germany: Export and Import Value, 2012-2015 ($Billion)
Figure 48: Germany: GDP – Composition of 2015, By End Use
Figure 49: France: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 50: France: GDP – Composition of 2015, By Sector of Origin
Figure 51: France: Export and Import Value, 2012-2015 ($Billion)
Figure 52: France: GDP – Composition of 2015, By End Use
Figure 53: Italy: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 54: Italy: GDP – Composition of 2015, By Sector of Origin
Figure 55: Italy : Export and Import Value, 2012-2015 ($Billion)
Figure 56: Italy : GDP – Composition of 2015, By End Use
Figure 57: Spain: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 58: Spain: GDP – Composition of 2015, By Sector of Origin
Figure 59: Spain: Export and Import Value, 2012-2015 ($Billion)
Figure 60: Spain: GDP – Composition of 2015, By End Use
Figure 61: U.K.: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 62: Germany: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 63: France: Regenerative Medicine Market  Revenue,2016-2022 ($Million) 
Figure 64: Italy: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 65: Spain: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 66: Russia: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 67: Rest of Europe: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 68: China: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 69: China: GDP – Composition of 2015, By Sector of Origin
Figure 70: China: Export and Import Value, 2012-2015 ($Billion)
Figure 71: China: GDP – Composition of 2015, By End Use
Figure 72: Japan: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 73: Japan: GDP – Composition of 2015, By Sector of Origin
Figure 74: Japan: Export and Import Value, 2012-2015 ($Billion)
Figure 75: Japan: GDP – Composition of 2015, By End Use
Figure 76: India: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 77: India: GDP – Composition of 2015, By Sector of Origin
Figure 78: India: Export and Import Value, 2012-2015 ($Billion)
Figure 79: India: GDP – Composition of 2015, By End Use
Figure 80: Australia: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 81: Australia: GDP – Composition of 2015, By Sector of Origin
Figure 82: Australia: Export and Import Value, 2012-2015 ($Billion)
Figure 83: Australia: GDP – Composition of 2015, By End Use
Figure 84: Japan: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 85: China: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 86: India: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 87: South Korea: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 88: Rest of APAC: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 89: Middle East: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 90: Africa: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 91: South America: Regenerative Medicine Market  Revenue, 2016-2022 ($Million)
Figure 92: Regenerative Medicines Market Entropy Share, By Strategies, 2013-2017 (%)
Figure 93: Regenerative Medicines Market Entropy, By Total Number of Developments, 2013-2017 
Figure 94: Athersys, Inc Net Revenues, By Years, 2011-2015 ($Million)
Figure 95: Exactech, Inc., Net Revenues, By Years, 2014-2016 ($ M)
Figure 96: Exactech, Inc., Net Revenue Share, By Business segments, 2016 (%)
Figure 97: Exactech, Inc., Net Sales Share, By Geography, 2016 (%)
Figure 98: Japan Tissue Engineering Co., Ltd Net Revenues, By Years, 2013-2015 ($Million)
Figure 99: Medtronic Net Sales, By Years, 2015-2016 ($Million)
Figure 100: Medtronic Net sales Share, By Geography, 2016 (%)
Figure 101: Medtronic Net Sales Share, By Business segments, 2016 (%)
Figure 102: Mesoblast Ltd . Net Revenues, By Years, 2013-2015 ($ M)
Figure 103: Mesoblast Ltd.  Net Revenue Share, By Business segments, 2016 (%)
Figure 104: Mesoblast Ltd. Net Sales Share, By Geography, 2016 (%)
Figure 105: Vertex Pharmaceuticals Inc. Net Revenues, By Years, 2013-2015 ($Billion)
Figure 106: Vertex Pharmaceuticals Inc. Net Revenue Share, By Business segments, 2015 (%)
Figure 107: Vertex Pharmaceuticals Inc. Net Sales Share, By Geography, 2015 (%)
Figure 108: Smith & Nephew plc, Net Revenues, By Years, 2014-2016 ($Million)
Figure 109: Smith & Nephew plc, Net Revenue Share, By Business segments, 2016 (%)
Figure 110: Smith & Nephew plc, Net Sales Share, By Geography, 2016 (%)
Figure 111: Vericel Corporation Net Revenue, By Years, 2014-2015 ($Million)
Figure 112: Nuvasive, Inc., Net Revenues, By Years, 2014-2016 ($Million)
Figure 113: Nuvasive, Inc., Net Sales Share, By Geography, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll